Parabilis Medicines, Inc.
SEC CIK 1657677 · PBLS · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sebulsky Alan | Director | filed 2026 - 2026 |
| Fitzgerald Edward M | Director | filed 2026 - 2026 |
| RA Capital Healthcare Fund LP | Director | filed 2026 - 2026 |
| Borisy Alexis | Director | filed 2026 - 2026 |
| RA Capital Management, LLC | Director | filed 2026 - 2026 |
| Kolchinsky Peter | Director | filed 2026 - 2026 |
| Shah Rajeev M. | Director | filed 2026 - 2026 |
| RA Capital Nexus Fund III, L.P. | Director | filed 2026 - 2026 |
| Yeshwant Krishna | Director | filed 2026 - 2026 |
| Klausner Richard | Director | filed 2026 - 2026 |
| Weber Barbara | Director | filed 2026 - 2026 |
| Simson Jake | Director | filed 2026 - 2026 |
| Mammen Mathai | Director · President & CEO | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mhatre Rohin | See Remarks | filed 2026 - 2026 |
| Kotarakos Thomas Rodolpho | Chief Financial Officer | filed 2026 - 2026 |
| Jurgensen Teresa | General Counsel | filed 2026 - 2026 |
| Benzaghou Mohammed Fawzi | Chief Medical Officer | filed 2026 - 2026 |
| Ho Helen Huei-in | See Remarks | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.